Membranous nephropathy in primary antiphospholipid syndrome

Affiliations

¹ AP-HP, Georges Pompidou European Hospital, Nephrology Department, Paris, France.
² AP-HP, Necker Hospital, Pathology Department, Paris, France.
³ Nancy University Hospital, Vascular Medicine Department, French Reference Center for Rare Systemic Auto-Immune and Auto-Inflammatory Diseases, Nancy, France.
⁴ University Hospital Center of Nîmes, Nephrology Department, Nîmes, France.
⁵ AP-HP, Bichat Hospital, Nephrology Department, Paris, France.
⁶ AP-HP, Tenon Hospital, Nephrology Department, Paris, France.
⁷ AP-HP, Bicêtre Hospital, Internal Medicine Department, Paris, France.
⁸ Montpellier University Hospital, Pathology Department, Montpelier, France.
⁹ AP-HP, Bicêtre Hospital, Pathology Department, Paris, France.
¹⁰ AP-HP, Bichat Hospital, Pathology Department, Paris, France.
¹¹ AP-HP, Tenon Hospital, Pathology Department, Paris, France.

Romain Stammler et al. Clin Kidney J. 2024.

. 2024 Feb 2;17(2):sfae017.

doi: 10.1093/ckj/sfae017. eCollection 2024 Feb.

¹ AP-HP, Georges Pompidou European Hospital, Nephrology Department, Paris, France.
² AP-HP, Necker Hospital, Pathology Department, Paris, France.
³ Nancy University Hospital, Vascular Medicine Department, French Reference Center for Rare Systemic Auto-Immune and Auto-Inflammatory Diseases, Nancy, France.
⁴ University Hospital Center of Nîmes, Nephrology Department, Nîmes, France.
⁵ AP-HP, Bichat Hospital, Nephrology Department, Paris, France.
⁶ AP-HP, Tenon Hospital, Nephrology Department, Paris, France.
⁷ AP-HP, Bicêtre Hospital, Internal Medicine Department, Paris, France.
⁸ Montpellier University Hospital, Pathology Department, Montpelier, France.
⁹ AP-HP, Bicêtre Hospital, Pathology Department, Paris, France.
¹⁰ AP-HP, Bichat Hospital, Pathology Department, Paris, France.
¹¹ AP-HP, Tenon Hospital, Pathology Department, Paris, France.

No abstract available

Conflict of interest statement

None declared.

1. Barbhaiya M, Taghavi M, Zuily Set al. . Efforts to better characterize “antiphospholipid antibody nephropathy” for the 2023 ACR/EULAR Antiphospholipid Syndrome Classification criteria: Renal Pathology Subcommittee report. J Rheumatol 2024;51:150–9. 10.3899/jrheum.2022-1200. - DOI - PubMed
1. Fakhouri F, Noël L-H, Zuber Jet al. . The expanding spectrum of renal diseases associated with antiphospholipid syndrome. Am J Kidney Dis 2003;41:1205–11. 10.1016/S0272-6386(03)00352-4. - DOI - PubMed
1. Sinico RA, Cavazzana I, Nuzzo Met al. . Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patients. Clin J Am Soc Nephrol 2010;5:1211–7. 10.2215/CJN.00460110. - DOI - PMC - PubMed
1. Sethi S, Beck LH, Glassock RJet al. . Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification. Kidney Int 2023;104:1092–102. 10.1016/j.kint.2023.06.032. - DOI - PubMed
1. Song YS, Min K-W, Kim JHet al. . Differential diagnosis of lupus and primary membranous nephropathies by IgG subclass analysis. Clin J Am Soc Nephrol 2012;7:1947–55. 10.2215/CJN.04800511. - DOI - PMC - PubMed